New approach for nicotine dependence treatment with cytisine (tabex)

  • strict warning: Non-static method view::load() should not be called statically in /home4/vibu/public_html/journalijdr.com/sites/all/modules/views/views.module on line 906.
  • strict warning: Declaration of views_handler_argument::init() should be compatible with views_handler::init(&$view, $options) in /home4/vibu/public_html/journalijdr.com/sites/all/modules/views/handlers/views_handler_argument.inc on line 744.
  • strict warning: Declaration of views_handler_filter::options_validate() should be compatible with views_handler::options_validate($form, &$form_state) in /home4/vibu/public_html/journalijdr.com/sites/all/modules/views/handlers/views_handler_filter.inc on line 607.
  • strict warning: Declaration of views_handler_filter::options_submit() should be compatible with views_handler::options_submit($form, &$form_state) in /home4/vibu/public_html/journalijdr.com/sites/all/modules/views/handlers/views_handler_filter.inc on line 607.
  • strict warning: Declaration of views_handler_filter_boolean_operator::value_validate() should be compatible with views_handler_filter::value_validate($form, &$form_state) in /home4/vibu/public_html/journalijdr.com/sites/all/modules/views/handlers/views_handler_filter_boolean_operator.inc on line 159.
  • strict warning: Non-static method view::load() should not be called statically in /home4/vibu/public_html/journalijdr.com/sites/all/modules/views/views.module on line 906.
  • strict warning: Non-static method view::load() should not be called statically in /home4/vibu/public_html/journalijdr.com/sites/all/modules/views/views.module on line 906.
Author: 
Sofiya A. Angelova, Emilia K. Naseva, Dinko G. Valev, Toma I. Avramov, and Antoaneta M. Manolova
Abstract: 

Introduction: The aim of this paper is to present new approach for nicotine dependence treatment with Cytisine (Tabex) and to compare it to the dosage regimen, prescribed by the manufacturer.
Material and Methods: 209 patients - smokers intended to quit smoking are divided randomly into two groups. Smokers in the first group are treated with Tabex according to the dosage scheme prescribed by the manufacturer. Patients in the second group are treated according to a new scheme: they stopped smoking from the beginning of the treatment and took 1 tablet of Tabex three times daily. Their treatment with Tabex continued at a dose of one tablet twice a day after the tenth day till 30th day; after 30th day – a maintenance dose of 1 tablet daily for up to 3 months. Both groups of patients were followed-up for one year.
Results and Discussion: The analysis shows that the new approach gives us better results in the tenth day, more sustainable results (after first year).
The observed incidence of adverse events was lower compared to patients treated with dose offered to us by the manufacturer. Despite the lower dose of cytisine, the new scheme is more effective as a nicotine replacement therapy.

Download PDF: 

CHIEF EDITOR

  

           Prof. Dr. Bilal BİLGİN

Call for Papers - 2017

    submit your paper now

   Vol. 07, Issue 03, March 2017

CURRENT ISSUE

 

Article Tracking

IMPACT FACTOR 2016

          4.753

Get your Certificate

Copyright © 2016 International Journal Development Research. All Rights Reserved.